Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?

Expert review of anticancer therapy - 1 Aug 2017

Falk Alexander T, Heeke Simon, Hofman Véronique, Lespinet Virginie, Ribeyre Camille, Bordone Olivier, Poudenx Michel, Otto Josiane, Garnier Georges, Castelnau Olivier, Guigay Joël, Leroy Sylvie, Marquette Charles-Hugo, Hofman Paul, Ilié Marius

Abstract excerpt

INTRODUCTION: The advent of genomic based precision medicine led to the implementation of biomarker testing in metastatic non-small cell lung cancer (NSCLC) patients. Next generation sequencing (NGS) has been recently implemented to routine diagnostic requirements in lung oncology. Areas covered: Two cases of patients with metastatic NSCLC for whom NGS analysis performed on both tumor and liquid biopsy has not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to High-Throughput Nucleotide Sequencing

Share to Lung Neoplasms

Share to Molecular Targeted Therapy

Share to Neoplasm Metastasis

Share to Precision Medicine

Source

Identifiers

PMID: 28511612
DOI: 10.1080/14737140.2017.1331736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?PMID 28511612Read ↗

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read ↗

Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.Semantic proximity Read ↗

Prospective clinical evaluation of cell-free DNA next generation sequencing in patients with suspected metastatic lung cancer.Semantic proximity Read ↗

Recent advance of next-generation sequencing in patients with lung cancer.Semantic proximity Read ↗

Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patientsSemantic proximity Read ↗

Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.Semantic proximity Read ↗

The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice.Semantic proximity Read ↗

The emerging roles of NGS-based liquid biopsy in non-small cell lung cancerSemantic proximity Read ↗

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and OpportunitiesSemantic proximity Read ↗

Liquid biopsy and its role in an advanced clinical trial for lung cancer.Semantic proximity Read ↗

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients.Semantic proximity Read ↗

Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.